Regen BioPharma delays Q2 Form 10-Q filing after accountant review lag

Reuters2026/08/13 17:51

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Regen BioPharma filed a late notice for its Form 10-Q for the quarter ended June 30, 2026.
The quarterly report was delayed by a holdup in its public accountant’s review.
The company expects to file the Form 10-Q by the fifth calendar day after the original due date.
It did not anticipate a significant change in results of operations versus the prior-year period.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regen BioPharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-037682), on August 13, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Regen BioPharma delays Q2 Form 10-Q filing after accountant review lag

You may also like

Crypto prices